Ovoca Bio (STU:OVXA) ROE % Adjusted to Book Value : -699.87% (As of Jun. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Ovoca Bio ROE % Adjusted to Book Value?

Ovoca Bio's ROE % for the quarter that ended in Jun. 2024 was -104.98%. Ovoca Bio's PB Ratio for the quarter that ended in Jun. 2024 was 0.15. Ovoca Bio's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -699.87%.

Ovoca Bio ROE % Adjusted to Book Value Historical Data

The historical data trend for Ovoca Bio's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovoca Bio ROE % Adjusted to Book Value Chart

Ovoca Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-17.88

-34.61

-38.91

-100.53

-713.69

Ovoca Bio Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-154.97	1.85	-138.50	-948.15	-699.87

Competitive Comparison of Ovoca Bio's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Ovoca Bio's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ovoca Bio's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ovoca Bio's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Ovoca Bio's ROE % Adjusted to Book Value falls into.

Ovoca Bio ROE % Adjusted to Book Value Calculation

Ovoca Bio's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-92.78%	/	0.13
	=	-713.69%

Ovoca Bio's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-104.98%	/	0.15
	=	-699.87%

Ovoca Bio ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Ovoca Bio's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovoca Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovoca Bio PLC (STU:OVXA) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

OVXA:Ireland OVB.GB:UK OVB:UK

Address

17 Pembroke Street Upper, Dublin, IRL, D02 AT22

Website

https://www.ovocabio.com

Ovoca Bio PLC is a life science investment company. The company is engaged in investing in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. The group has two business segments, bio-pharmaceutical and investment, which are operated principally in Russian Federation and investment activities operated from Bermuda, and with administrative activities in the Republic of Ireland. Its product candidate includes IVIX - Libicore - a novel synthetic peptide, administrated through a nasal spray.

Ovoca Bio Headlines

No Headlines